President Donald Trump said that U.S. pharmaceutical companies have discussed “recently developed” treatment for UK Prime Minister Boris Johnson, who was admitted to intensive care on Monday afternoon with the CCP virus.
Johnson was diagnosed with the CCP (Chinese Communist Party) virus, also known as the novel coronavirus, on March 27. His condition worsened over Monday afternoon and he was moved to intensive care on the advice of his medical team.